IFI-M · PS Tissue-Specific Series

Specimen SS-F-M2-03204 // MULTI-AXIS · IFI-M

PS Tissue-Specific Series II-IV-C

Brassica nigra

Black Mustard

Tier IIPS Tissue-Specific Series

Target Trait

1.9×

fold-change

Sharp+Sweet tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-03204

Genomic Edits

7

GC Content

43.9%

Construct Length

3,990 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + TAS1R2/TAS1R3

IFI Score

190

Pathway Edits

  • TRPA1 pathway primary gene cluster overexpression for sharp axis activation
  • TAS1R2/TAS1R3 pathway primary gene cluster overexpression for sweet axis activation
  • Bidirectional promoter system for synchronized P+S dual-axis co-expression
  • Metabolic flux partitioning between IFI-P and IFI-S pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Sharp-Sweet combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for P+S simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized PS spatial patterning

Key Interventions

Dual-receptor co-activation via synchronized TRPA1 and TAS1R2/TAS1R3 pathway engineeringMetabolic flux partitioning strategy enabling simultaneous sharp and sweet accumulation without competing pathway suppressionTissue-specific dual expression for PS multi-axis integrationCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II PS dual-axis tissue-specific platform for food ingredient applications requiring verified combined sharp+sweet sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$849 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities